Merck Emend (aprepitant) for oral suspension recall
FDA recall D-0241-2026 · initiated Dec 12, 2025
Merck Sharp & Dohme LLC recalled Merck Emend (aprepitant) for oral suspension in Dec 2025 — an FDA Class II recall (D-0241-2026) because Presence of particulate matter: potential presence of metal particulates in the product.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Presence of particulate matter: potential presence of metal particulates in the product.
Something got into the product
A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 3 - single dose kits
Details
- Product
- Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
- Recalling company
- Merck Sharp Dohme
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- Nationwide in the USA
- Initiated
- Dec 12, 2025
- FDA report date
- Dec 31, 2025
This recall is linked to a product we cover: Emend →
Frequently asked
- Was Merck Emend (aprepitant) for oral suspension recalled?
- Merck Sharp & Dohme LLC recalled Merck Emend (aprepitant) for oral suspension in Dec 2025 — an FDA Class II recall (D-0241-2026) because Presence of particulate matter: potential presence of metal particulates in the product. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was Merck Emend (aprepitant) for oral suspension recalled?
- Per the FDA enforcement record, the reason for recall D-0241-2026 was: Presence of particulate matter: potential presence of metal particulates in the product.
- Is a recalled Merck Emend (aprepitant) for oral suspension dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Merck Emend (aprepitant) for oral suspension are affected?
- Distributed: Nationwide in the USA. The recall covers these lots — Lot #: Z014503, Exp 11/15/2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0241-2026.